King's College London boasts the largest medical school in Europe. Its Department of Clinical Neuroscience has 190 members, including 10 full professors and 17,000,000 Euros of current grant income. The Department of Clinical Neuroscience includes the Cochrane Neuromuscular Disease Group editorial base led by Professor R Hughes. This receives core funding from the UK National Health Service Department of Health and has published 40 systematic reviews of interventions for neuromuscular diseases in the Cochrane Library.

The Cochrane Neuromuscular Disease Group is part of the international Cochrane Collaboration, which aims to help people make well-informed decisions about health care by preparing, maintaining and promoting the accessibility of systematic reviews of the health interventions and through the Collaboration has access to frontline developments in systematic reviewing methodology and promotion and circulation of the Cochrane Library.

The Cochrane Neuromuscular Disease Group has over 270 members including clinicians, researchers and allied health professionals based throughout the world with an interest in the development of systematic reviews of interventions for treating neuromuscular disease.

Website
http://www.kcl.ac.uk/cochranenmd 
 

Michael Rose (PhD, FRCP) : Editor Cochrane Neuromuscular Disease Group. More than 50 original articles in journals. Systematic review writer and outcome measurement expert.

Kate Jewitt (BA): The first point of contact for authors wishing to undertake a systematic review or for general enquiries about the work of the group.